Saturday 17 October 2026 Export PAIYY’s income statement to Excel — free account

Aesthetic Medical International Hldngs Group Ltd Sponsored ADR

PAIYY Healthcare Medical Care Facilities

In the quarter to June 2025, revenue grew 25,427.4% and EPS grew 76.8%, each against the same quarter a year earlier.

0.01 0.00 0.00%

Follow PAIYY

Alert me

Market cap: $15.9M
P/E: 0.0×
Fwd P/E: 8.3×
Dividend yield: —
F-score: 5/9
Altman Z: n/a
Beneish M: −2.30
Dividend safety: 12/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 1.97%

Capital & Financial Ratios $m

Market Cap 15.93

Revenue 164.60

Net Income 0.00

Free Cash Flow (27.34)

Net Debt 7.40

Current Ratio 0.24

Debt/Equity 42.40

P/E ratio 0.00

Fwd P/E 8.27

P/S ratio 0.00

P/B ratio 1.85

Past 5Y EPS Growth —

This Y EPS Growth —

Next Y EPS Growth —

Next Y revenue growth 1,163.15%

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 0.57%

10-year low 10-year high

P/B against its own 10 years 14.96%

10-year low 10-year high

EV/Sales against its own 10 years 0.57%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2022	2023	2024	2025
Cash	2	9	6	9
Receivables	5	5	4	7
Inventory	4	2	2	3
Other	—	—	—	—
	12	16	12	19

	2022	2023	2024	2025
Payables	7	6	7	5
ST’ Debt	26	10	10	18
Other	26	27	27	26
	81	58	56	60

Compound Annual Growth %

	10y	5y	3y
Sales	—	(5.10%)	0.32%
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	49	—	—	101
’24	—	50	—	—	105
’23	22	44	—	—	96
’22	25	51	23	0	100
’21	32	35	—	—	100
’20	13	24	41	53	131

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	(2)
’24	—	—	—	—	11
’23	—	—	—	—	10
’22	—	—	—	—	(11)
’21	—	—	—	—	8
’20	—	—	—	—	0

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	(2)
’24	—	—	—	—	7
’23	—	—	—	—	3
’22	—	—	—	(11)	(11)
’21	7	2	—	—	3
’20	—	—	—	(7)	(7)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	(0.03)	—	—	(0.16)
’24	—	(0.06)	—	—	(0.07)
’23	0.00	(0.03)	—	—	(0.13)
’22	(0.02)	(0.02)	(0.24)	(0.12)	(0.41)
’21	(0.12)	(1.65)	—	—	(4.20)
’20	(0.51)	(0.39)	(0.12)	(0.54)	(1.65)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	6.03	3.81	1.95	1.04	0.48	0.12	0.04	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	12.56	10.66	11.24	3.80	1.70	0.90	0.34
People
People	Employees	—	—	1,687	1,550	1,665	1,665	1,167	1,286	1,309	1,139
	Revenue/emp, $m	0.00	0.00	0.07	0.08	0.08	0.06	0.09	0.07	0.08	0.09
Income, $m
Income, $m	Revenue	88	103	115	126	131	100	100	96	105	101
	Gross margin, %	62.84	66.37	66.04	68.25	60.43	41.74	53.07	47.18	44.70	46.24
	EBT	9	(8)	(35)	22	(38)	(106)	(14)	(8)	0	(3)
	EBT margin, %	10.71	(7.42)	(30.73)	17.53	(28.78)	(105.53)	(14.05)	(8.07)	(0.18)	(3.42)
	Net income	8	0	(35)	22	(38)	(106)	(14)	(8)	0	(3)
	Depreciation	6	4	5	12	15	15	9	9	9	8
Per share, $
Per share, $	Revenue	3.67	4.30	8.40	8.18	6.00	4.55	3.65	2.20	2.20	2.10
	Earnings	0.11	(0.16)	(2.79)	1.29	(1.65)	(4.20)	(0.41)	(0.15)	(0.06)	(0.16)
	Cash flow	0.31	0.44	0.33	0.82	(0.01)	0.36	(0.41)	0.24	0.23	(0.04)
	Capex	0.00	0.00	(0.86)	(0.72)	(0.30)	(0.23)	(0.01)	(0.18)	(0.09)	0.00
	Free cash flow	0.31	0.44	(0.53)	0.10	(0.31)	0.13	(0.42)	0.06	0.14	(0.04)
	Book value	0.00	(0.30)	(2.75)	5.56	2.83	(1.31)	(0.69)	0.11	0.03	(0.13)
	Shares, m	24	24	14	15	22	22	27	44	48	48
Valuation, ×
Valuation, ×	P/E	13.37	13.37	13.37	17.35	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	0.00	0.00	0.00	0.00	0.88	0.50	0.38	0.32	0.13	0.05
	P/B	0.00	0.00	0.00	1.16	1.86	5.16	0.00	6.54	10.59	31.46
	EV/Sales	0.00	0.00	0.00	0.00	1.09	0.68	0.66	0.40	0.21	0.09
	EV/FCF	0.00	0.00	0.00	7.31	12.37	21.08	(2.41)	(1.31)	(0.89)	(0.57)
Cash, $m
Cash, $m	Operating cash flow	7	11	5	13	0	8	(11)	10	11	(2)
	Capex	(6)	(7)	(12)	(11)	(7)	(5)	0	(8)	(4)	0
	Free cash flow	7	11	(7)	2	(7)	3	(11)	3	7	(2)
Balance, $m
Balance, $m	Working capital	—	14	17	0	(14)	(66)	(69)	(42)	(44)	(41)
	Total debt	—	75	25	20	36	42	30	15	12	20
	Net debt	—	58	10	(2)	28	36	28	6	6	11
	Shareholders’ equity	—	(7)	(38)	85	62	(29)	(19)	5	1	(6)
Returns, %
Returns, %	ROA	0.00	(12.11)	(74.64)	15.55	(22.60)	(75.82)	(13.28)	(6.59)	(3.78)	(10.70)
	ROIC	—	0.00	0.00	(2.33)	(22.62)	(491.74)	(67.90)	(44.68)	(16.40)	(42.40)
	ROE	0.00	47.52	170.03	82.56	(46.38)	(554.53)	47.61	75.81	(91.69)	314.85

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2025

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
BTMD biote Corp.	$39.9M	6.8×	11.0×	−9.48% (below 0%: shrinking)	n/m	−174.16% (below 0%: shrinking)	65.38%	(7.93%)	Compare
PIII P3 Health Partners Inc.	$30.1M	— (loss-making)	—	+8.60% (above 0%: growing)	n/m	−272.24% (below 0%: shrinking)	22.26%	10.67%	Compare
CCEL Cryo-Cell International Inc.	$29.4M	— (loss-making)	43.8×	−0.02% (below 0%: shrinking)	+77.78% (above 0%: growing)	−58.37% (below 0%: shrinking)	79.38%	28.04%	Compare
DCGO DocGo Inc.	$27.9M	— (loss-making)	— (loss-making)	−8.70% (below 0%: shrinking)	n/m	−132.28% (below 0%: shrinking)	30.52%	(24.41%)	Compare
PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR	$15.9M	— (loss-making)	8.3×	+25,427.42% (above 0%: growing)	n/m	−206.36% (below 0%: shrinking)	42.70%	(1.24%)
CCM Concord Medical Services Holdings Limited	$10.5M	— (loss-making)	— (loss-making)	+37.65% (above 0%: growing)	n/m	−281.45% (below 0%: shrinking)	(13.15%)	0.00%	Compare
AMS American Shared Hospital Services	$8.4M	— (loss-making)	1.8×	+19.22% (above 0%: growing)	n/m	+195.82% (above 0%: growing)	17.00%	(7.22%)	Compare
CANOQ Cano Health, Inc.	$6.6M	— (loss-making)	—	−21.05% (below 0%: shrinking)	n/m	−43.68% (below 0%: shrinking)	100.00%	(16.23%)	Compare
MODVQ ModivCare Inc.	$6.2M	— (loss-making)	— (loss-making)	−3.18% (below 0%: shrinking)	n/m	−3,767.70% (below 0%: shrinking)	14.06%	(1.78%)	Compare
Median of peers	$19.2M	—	11.0×	−1.60%	—	−153.22%	26.39%	(4.50%)

All 55 Medical Care Facilities stocks →